Results 231 to 240 of about 24,923 (301)

Rocavorexant, a novel, selective orexin‐1 receptor antagonist: Safety, tolerability and pharmacokinetics in healthy adults and individuals with opioid use disorder

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Rocavorexant (INDV‐2000), a selective orexin‐1 receptor antagonist, reduces drug self‐administration and anxiety in nonclinical studies. This Phase 1 programme evaluated the safety, pharmacokinetics and pharmacodynamics of rocavorexant in healthy volunteers and treatment‐seeking individuals with opioid use disorder (OUD).
Martin Kankam   +5 more
wiley   +1 more source

Combined transcatheter mitral and tricuspid edge-to-edge repair or tricuspid edge-to-edge repair alone in moderate mitral regurgitation: a propensity-matched analysis. [PDF]

open access: yesEur Heart J
Kassar M   +54 more
europepmc   +1 more source

Influence of age, frailty and non-cardiac comorbidities on survival in patients undergoing mitral valve edge-to-edge repair - a perspective from the German health care system. [PDF]

open access: yesInt J Cardiol Heart Vasc
Piayda K   +12 more
europepmc   +1 more source

Early Single-Leaflet Device Attachment After TEER: Device Orientation in Complex Mitral Anatomy. [PDF]

open access: yesJACC Case Rep
Ververeli CL   +8 more
europepmc   +1 more source

TRI-SCORE based risk stratification across contemporary treatment strategies for isolated tricuspid regurgitation: a multicenter retrospective analysis. [PDF]

open access: yesFront Cardiovasc Med
Gharehdaghi S   +13 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy